Goulart, H., Jabbour, E., Jain, N., Kadia, T., DiNardo, C., Daver, N., Pemmaraju, N., Chien, K., Haddad, F., Senapati, J., Khouri, R., Ravandi, F., Garcia-Manero, G., Garris, R., Short, N., Kantarjian, H. (2025). Blinatumomab and ponatinib demonstrates ongoing efficacy as frontline therapy in Philadelphia positive B-cell acute lymphoblastic leukemia: Long-term follow-up from a phase 2 Study. Blood. https://doi.org/10.1182/blood-2025-1571